$3.690
-0.154 (-4.16%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
IRD Prediction & Forecast by Similar Chart Analysis
Alphio's IRD stock price prediction model matches the current Opus Genetics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.70 (+0.35%). The 1-week path is $3.76 (+1.85%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Opus Genetics Inc Stock?
Opus Genetics Inc (IRD) is a good buy right now due to its current price of $3.69, which is significantly lower than analyst price targets of $9 and $13, indicating substantial upside potential. The company's recent alignment with the FDA on its Phase 3 trial design for a gene therapy product is a strong positive catalyst, which could lead to increased investor interest. However, the main risk is the negative net income reported at -65,535,000 USD for Q1 2026, which highlights ongoing financial challenges.
IRD stock price ended at $3.69 on Friday, after losing -4.16%
Opus Genetics Inc (IRD) last closed at $3.69, losing -4.16%. These facts feed the 1-day and 1-week IRD price prediction above.
Forecast Drivers
Opus Genetics Inc (IRD) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches IRD, ranked by similarity.
Seasonality analysis for IRD
Historically the probability of a positive August return for IRD is 31.75%. December offers the highest probability of a positive month at 51.16%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for IRD
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $1.40 | $1.68 | $2.14 | -54.43% |
| Sep 2026 | $1.41 | $1.60 | $2.04 | -56.70% |
| Oct 2026 | $1.36 | $1.62 | $2.10 | -56.22% |
| Nov 2026 | $1.12 | $1.63 | $1.91 | -55.72% |
| Dec 2026 | $0.82 | $1.26 | $1.53 | -65.93% |
In 2026, Opus Genetics Inc (IRD) is projected to range from $0.82 to $2.14.
Opus Genetics Inc 2026 monthly forecast
In Aug 2026, Opus Genetics Inc is projected to average $1.68, with a low of $1.40 and high of $2.14.
In Sep 2026, Opus Genetics Inc is projected to average $1.60, with a low of $1.41 and high of $2.04.
In Oct 2026, Opus Genetics Inc is projected to average $1.62, with a low of $1.36 and high of $2.10.
In Nov 2026, Opus Genetics Inc is projected to average $1.63, with a low of $1.12 and high of $1.91.
In Dec 2026, Opus Genetics Inc is projected to average $1.26, with a low of $0.82 and high of $1.53.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.